Gilead Sciences Future Growth
Future criteria checks 2/6
Gilead Sciences is forecast to grow earnings and revenue by 7.8% and 2.1% per annum respectively while EPS is expected to grow by 9% per annum.
Key information
7.8%
Earnings growth rate
9.0%
EPS growth rate
Biotechs earnings growth | 31.8% |
Revenue growth rate | 2.1% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 22 Sep 2023 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2025 | 28,265 | 6,996 | 9,669 | 9,740 | 22 |
12/31/2024 | 27,519 | 6,621 | 9,496 | 9,628 | 25 |
12/31/2023 | 26,872 | 5,763 | 8,791 | 8,916 | 25 |
6/30/2023 | 27,382 | 5,484 | 8,926 | 9,512 | N/A |
3/31/2023 | 27,043 | 5,583 | 8,386 | 8,976 | N/A |
12/31/2022 | 27,281 | 4,592 | 8,344 | 9,072 | N/A |
9/30/2022 | 27,136 | 3,334 | 9,007 | 9,710 | N/A |
6/30/2022 | 27,515 | 4,137 | 9,415 | 10,100 | N/A |
3/31/2022 | 27,472 | 4,515 | 9,953 | 10,614 | N/A |
12/31/2021 | 27,305 | 6,225 | 10,805 | 11,384 | N/A |
9/30/2021 | 27,482 | 7,394 | 9,491 | 10,095 | N/A |
6/30/2021 | 26,638 | 5,162 | 8,472 | 9,092 | N/A |
3/31/2021 | 25,564 | 301 | 8,698 | 9,342 | N/A |
12/31/2020 | 24,689 | 123 | 7,518 | 8,168 | N/A |
9/30/2020 | 23,147 | 1,268 | 8,160 | 8,832 | N/A |
6/30/2020 | 22,174 | -257 | 8,510 | 9,227 | N/A |
3/31/2020 | 22,716 | 4,962 | 8,244 | 9,003 | N/A |
12/31/2019 | 22,449 | 5,386 | 8,319 | 9,144 | N/A |
9/30/2019 | 22,365 | 2,693 | 8,039 | 8,909 | N/A |
6/30/2019 | 22,357 | 5,955 | 7,639 | 8,476 | N/A |
3/31/2019 | 22,320 | 5,892 | 6,758 | 7,707 | N/A |
12/31/2018 | 22,127 | 5,455 | 7,476 | 8,400 | N/A |
9/30/2018 | 22,281 | 1,587 | 7,912 | 8,808 | N/A |
6/30/2018 | 23,197 | 2,208 | 8,432 | 9,290 | N/A |
3/31/2018 | 24,690 | 3,464 | 10,559 | 11,243 | N/A |
12/31/2017 | 26,107 | 4,628 | 11,308 | 11,898 | N/A |
9/30/2017 | 27,478 | 11,601 | 12,145 | 12,684 | N/A |
6/30/2017 | 28,466 | 12,213 | 13,775 | 14,383 | N/A |
3/31/2017 | 29,101 | 12,637 | N/A | 15,842 | N/A |
12/31/2016 | 30,390 | 13,501 | N/A | 17,047 | N/A |
9/30/2016 | 31,576 | 15,076 | N/A | 18,382 | N/A |
6/30/2016 | 32,371 | 16,346 | N/A | 18,085 | N/A |
3/31/2016 | 32,839 | 17,341 | N/A | 18,758 | N/A |
12/31/2015 | 32,639 | 18,108 | N/A | 21,250 | N/A |
9/30/2015 | 31,447 | 16,912 | N/A | 18,476 | N/A |
6/30/2015 | 29,194 | 15,043 | N/A | 18,424 | N/A |
3/31/2015 | 27,485 | 14,207 | N/A | 16,951 | N/A |
12/31/2014 | 24,890 | 12,101 | N/A | 12,818 | N/A |
9/30/2014 | 20,696 | 9,406 | N/A | 10,524 | N/A |
6/30/2014 | 17,437 | 7,463 | N/A | 7,233 | N/A |
3/31/2014 | 13,669 | 4,580 | N/A | 4,001 | N/A |
12/31/2013 | 11,202 | 3,075 | N/A | 3,105 | N/A |
9/30/2013 | 10,585 | 3,046 | N/A | 3,084 | N/A |
6/30/2013 | 10,229 | 2,933 | N/A | 3,076 | N/A |
3/31/2013 | 9,867 | 2,872 | N/A | 3,414 | N/A |
12/31/2012 | 9,702 | 2,592 | N/A | 3,195 | N/A |
9/30/2012 | 9,315 | 2,494 | N/A | 3,467 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 000935700's forecast earnings growth (7.8% per year) is above the savings rate (0.01%).
Earnings vs Market: 000935700's earnings (7.8% per year) are forecast to grow faster than the Swiss market (7.5% per year).
High Growth Earnings: 000935700's earnings are forecast to grow, but not significantly.
Revenue vs Market: 000935700's revenue (2.1% per year) is forecast to grow slower than the Swiss market (3.9% per year).
High Growth Revenue: 000935700's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 000935700's Return on Equity is forecast to be high in 3 years time